NanObioTech.us
About NanObioTech.us
Nanobiotech, LLC is a closely-held company established by Gary S. Mezo in 2004. Mezo is the founder and past chairman/CEO of Nanobac Pharmaceuticals, Inc., a US public company. At Nanobac Mezo developed the first nanobiotics effective against Nanobacteria (aka Nanobacterium sanguineum, Calcifying Nanoparticles and CNP). The first nanobiotic, NanobacTX, targeted atherosclerosis and specifically, Coronary Artery Disease.
